A carregar...

A novel pre-clinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity

RATIONALE: 1) Despite intense interest in strategies to predict which kinase inhibitor (KI) cancer therapeutics may be associated with cardiotoxicity, current approaches are inadequate. 2) Sorafenib is a KI of concern since it inhibits growth factor receptors and Raf-1/B-Raf, kinases that are upstre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cheng, Hui, Kari, Gabor, Dicker, Adam P, Rodeck, Ulrich, Koch, Walter J, Force, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908774/
https://ncbi.nlm.nih.gov/pubmed/21998323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.111.255695
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!